The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David H. Gutmann

Washington University School of Medicine

Department of Neurology and Washington University Neurofibromatosis Center

660 South Euclid Avenue

St. Louis

USA

[email]@*.wustl.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Washington University School of Medicine, Department of Neurology and Washington University Neurofibromatosis Center, 660 South Euclid Avenue, St. Louis, USA. 2013
  • Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA. 1998 - 2009
  • Department of Neurology, Washington University School of Medicine, and The Neurofibromatosis Program, St. Louis Children's Hospital, USA. 2002
  • Department of Neurology, Center for the Study of Nervous System Injury and Neurofibromatosis Program, Washington University School of Medicine, St Louis, USA. 2001
  • Washington University, St Louis, MO 63110, USA. 1997

References

  1. Optimizing biologically targeted clinical trials for neurofibromatosis. Gutmann, D.H., Blakeley, J.O., Korf, B.R., Packer, R.J. Expert. Opin. Investig. Drugs (2013) [Pubmed]
  2. Modeling human brain tumors in mice. Gutmann, D.H. Brain Pathol. (2009) [Pubmed]
  3. Mouse Models of Human Cancers Consortium Workshop on Nervous System Tumors. Gutmann, D.H., Maher, E.A., Van Dyke, T. Cancer Res. (2006) [Pubmed]
  4. Harnessing preclinical mouse models to inform human clinical cancer trials. Gutmann, D.H., Hunter-Schaedle, K., Shannon, K.M. J. Clin. Invest. (2006) [Pubmed]
  5. Mouse models of human cancer consortium symposium on nervous system tumors. Gutmann, D.H., Baker, S.J., Giovannini, M., Garbow, J., Weiss, W. Cancer Res. (2003) [Pubmed]
  6. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Gutmann, D.H., Winkeler, E., Kabbarah, O., Hedrick, N., Dudley, S., Goodfellow, P.J., Liskay, R.M. Oncogene (2003) [Pubmed]
  7. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Gutmann, D.H., James, C.D., Poyhonen, M., Louis, D.N., Ferner, R., Guha, A., Hariharan, S., Viskochil, D., Perry, A. Neurology (2003) [Pubmed]
  8. Mouse glioma gene expression profiling identifies novel human glioma-associated genes. Gutmann, D.H., Huang, Z.Y., Hedrick, N.M., Ding, H., Guha, A., Watson, M.A. Ann. Neurol. (2002) [Pubmed]
  9. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Gutmann, D.H., Hedrick, N.M., Li, J., Nagarajan, R., Perry, A., Watson, M.A. Cancer Res. (2002) [Pubmed]
  10. Mouse models of neurofibromatosis 1 and 2. Gutmann, D.H., Giovannini, M. Neoplasia (2002) [Pubmed]
  11. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Gutmann, D.H., Rasmussen, S.A., Wolkenstein, P., MacCollin, M.M., Guha, A., Inskip, P.D., North, K.N., Poyhonen, M., Birch, P.H., Friedman, J.M. Neurology (2002) [Pubmed]
  12. Neurofibromin in the brain. Gutmann, D.H. J. Child Neurol. (2002) [Pubmed]
  13. The neurofibromatoses: when less is more. Gutmann, D.H. Hum. Mol. Genet. (2001) [Pubmed]
  14. The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility. Gutmann, D.H., Haipek, C.A., Burke, S.P., Sun, C.X., Scoles, D.R., Pulst, S.M. Hum. Mol. Genet. (2001) [Pubmed]
  15. Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Gutmann, D.H., Hirbe, A.C., Haipek, C.A. Hum. Mol. Genet. (2001) [Pubmed]
  16. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Gutmann, D.H., Wu, Y.L., Hedrick, N.M., Zhu, Y., Guha, A., Parada, L.F. Hum. Mol. Genet. (2001) [Pubmed]
  17. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Gutmann, D.H., Zhang, Y., Hasbani, M.J., Goldberg, M.P., Plank, T.L., Petri Henske, E. Acta Neuropathol. (2000) [Pubmed]
  18. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Gutmann, D.H., Donahoe, J., Perry, A., Lemke, N., Gorse, K., Kittiniyom, K., Rempel, S.A., Gutierrez, J.A., Newsham, I.F. Hum. Mol. Genet. (2000) [Pubmed]
  19. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Gutmann, D.H., Donahoe, J., Brown, T., James, C.D., Perry, A. Neuropathol. Appl. Neurobiol. (2000) [Pubmed]
  20. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. Gutmann, D.H., Haipek, C.A., Hoang Lu, K. J. Neurosci. Res. (1999) [Pubmed]
  21. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Gutmann, D.H., Sherman, L., Seftor, L., Haipek, C., Hoang Lu, K., Hendrix, M. Hum. Mol. Genet. (1999) [Pubmed]
  22. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Gutmann, D.H., Geist, R.T., Xu, H., Kim, J.S., Saporito-Irwin, S. Hum. Mol. Genet. (1998) [Pubmed]
  23. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. Gutmann, D.H., Aylsworth, A., Carey, J.C., Korf, B., Marks, J., Pyeritz, R.E., Rubenstein, A., Viskochil, D. JAMA (1997) [Pubmed]
 
WikiGenes - Universities